Infusion of casirivimab and imdevimab, given for off label use to treat COVID-19 in patients who are at high risk for progression to severe disease or hospitalization.
Infusion of casirivimab and imdevimab, given for off label use to treat COVID-19 in patients who are at high risk for progression to severe disease or hospitalization.
